A group of women’s health advocates are asking the entire Sixth Circuit Court of Appeals to weigh in on an Ohio law that bans the off-label use of mifepristone.
Telemedicine administration of medical abortion is a relatively new practice in the United States with great potential to reach underserved women with abortion care.
The group is claiming that a Lafayette clinic is violating law by providing medication abortions without licensing their clinic as a surgical abortion center.
Act 217 has caused the state’s only other medication abortion provider to also stop offering RU-486 abortions.
Who are you going to believe, doctors, or politicians?
No doctor wants to be charged as a felon, and with Act 217 in effect, it’s almost impossible to avoid that risk.
A recent Associated Press story mis-reported that a bill in Alabama would restrict access to emergency contraception. In fact, the bill restricts medical abortion, a safe, easy method of early termination. The whole incident underscores why it’s important for the mainstream media to be clear on these distinctions.
What do you get when you cross legislation on who can provide an exam before administering RU-486 with new rules on admitting privileges and other standards for doctors who provide abortions? SuperTRAP.
A recent federal district court decision upholding a 2004 Ohio limiting the use and availability of RU-486 for early termination of pregnancy exacerbates the increasing intrusion of ideology into medical practice, and creates a different standard for off-label use of abortion drugs than for other commonly-used drugs.
Georgia will use federal TANF money for domestic violence shelters which could eliminate services for women without children, what do state ant-abortion bills say about women, Arizona enacts more anti-abortion legislation, and Starbucks selling a maternal health benefit CD.